Stephen David Robinson

Stephen David Robinson

Auto-generated profile, based on publicly available information

Stephen David Robinson

Sussex Cancer Centre, University Hospitals Sussex NHS Foundation Trust, Brighton, UK.

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
LDLucy B. Diss
Lucy B. Diss
SRStephen D. Robinson
Stephen D. Robinson
YWYukyee Wu
Yukyee Wu
SFSara Fidalgo
Sara Fidalgo
MYMark S. Yeoman
Mark S. Yeoman
BPBhavik Patel
Bhavik Patel

1 November 2018 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Open access
BTBilal A. Tahir
Bilal A. Tahir
PHPaul J.C. Hughes
Paul J.C. Hughes
SRStephen D. Robinson
Stephen D. Robinson
HMHelen Marshall
Helen Marshall
NSNeil J. Stewart
Neil J. Stewart
RIRob H. Ireland
Rob H. Ireland
To develop and apply an image acquisition and analysis strategy for spatial comparison of computed tomography (CT)-ventilation images with hyperpolarized gas magnetic resonance imaging (MRI). Eleven lung cancer patients underwent xenon-129 (129Xe) and helium-3 (3He) ventilation MRI and coregistered proton (1H) anatomic MRI. Expiratory and inspiratory breath-hold CTs were used for deformable image registration and calculation of 3 CT-ventilation metrics: Hounsfield unit (CTHU), Jacobian (CTJac), and specific gas volume change (CTSGV). Inspiration CT and hyperpolarized gas ventilation MRI were registered via same-breath anatomic 1H-MRI. Voxel-wise Spearman correlation coefficients were calculated between each CT-ventilation image and its corresponding 3He-/129Xe-MRI, and for the mean values in regions of interest (ROIs) ranging from fine to coarse in-plane dimensions of 5 × 5, 10 × 10, 15 × 15, and 20 × 20, located within the lungs as defined by the same-breath 1H-MRI lung mask. Correlation of 3He and 129Xe-MRI was also assessed. Spatial correlation of CT-ventilation against 3He/129Xe-MRI increased with ROI size. For example, for CTHU, mean ± SD Spearman coefficients were 0.37 ± 0.19/0.33 ± 0.17 at the voxel-level and 0.52 ± 0.20/0.51 ± 0.18 for 20 × 20 ROIs, respectively. Correlations were stronger for CTHU than for CTJac or CTSGV. Correlation of 3He with 129Xe-MRI was consistently higher than either gas against CT-ventilation maps over all ROIs (P < .05). No significant differences were observed between CT-ventilation versus 3He-MRI and CT-ventilation versus 129Xe-MRI. Comparison of ventilation-related measures from CT and registered hyperpolarized gas MRI is feasible at a voxel level using a dedicated acquisition and analysis protocol. Moderate correlation between CT-ventilation and MRI exists at a regional level. Correlation between MRI and CT is significantly less than that between 3He and 129Xe-MRI, suggesting that CT-ventilation surrogate measures may not be measuring lung ventilation alone.

1 July 2024 in BMC Methods
Verified
Journal Article
Open access
PDF file
SRStephen David Robinson
Stephen David Robinson
MSMark Samuels
Mark Samuels
WJWilliam Jones
William Jones
NSNicolas Stewart
Nicolas Stewart
MEMurat Eravci
Murat Eravci
Georgios GiamasGeorgios Giamas
Georgios Giamas
Background: Extracellular vesicles (EVs) are amongst the most promising candidates for developing blood-based biomarkers. However, patient sample availability is a key barrier to translational research whilst most biobanks store samples of 1.5mL volume or less. To date, there is no consensus on the most suitable method of EV separation and current techniques frequently require large volumes of biofluids, complicated technology, technical expertise, or significant operating costs, which prevents their widespread adoption by less EV-focussed laboratories. Therefore, there is a need for an easy and reproducible method that separates representative EVs from clinically relevant 1mL volumes of plasma prior to subsequent biomarker identification. Methods: In this study, EVs were separated from a clinically relevant 1mL volume of human plasma using four different separation techniques: size exclusion chromatography (SEC), differential ultracentrifugation, precipitation, and immunoaffinity magnetic bead capture. The EVs were characterised using several orthogonal techniques (protein quantification, nanoparticle tracking analysis, transmission electron microscopy, Western blot, single particle interferometric reflectance imaging sensing, and mass spectrometry-based proteomics) to comprehensively compare the separated samples. Results: We provide examples of anticipated results highlighting that SEC-processed samples have greater protein quantification yield, greater particle yield of the expected size for EVs, and sufficient EV purity, which facilitates effective EV cargo assessment by proteomics. Moreover, we confirm significant overlap with known EV-related proteins within the Vesiclepedia database. Additionally, using single particle interferometric reflectance imaging sensing (Leprechaun®), we identify that SEC has the most representative surface tetraspanin distribution of the separated EV population compared to unprocessed plasma. Discussion: Given that SEC requires minimal expertise, no complicated technology and can separate EVs within 90 min, this comparison reinforces SEC as a clinically relevant EV separation method from 1mL of plasma making it suitable for widespread implementation.

1 May 2021 in Prostate Cancer and Prostatic Diseases
Verified
Journal Article
Closed access
PDF file
MSMarieke Van Son
Marieke Van Son
MPMax Peters
Max Peters
DRDeepika Reddy
Deepika Reddy
TSTaimur T. Shah
Taimur T. Shah
FHFeargus Hosking-Jervis
Feargus Hosking-Jervis
AFAlison Falconer
Alison Falconer

5 September 2023 in Oncogene
Verified
Journal Article
Open access
PDF file
MSMark Samuels
Mark Samuels
WJWilliam Jones
William Jones
BTBenjamin Towler
Benjamin Towler
CTCharlotte Turner
Charlotte Turner
SRStephen Robinson
Stephen Robinson
Georgios GiamasGeorgios Giamas
Georgios Giamas
Breast Cancer (BC) is the most common form of cancer worldwide, responsible for 25% of cancers in women. Whilst treatment is effective and often curative in early BC, metastatic disease is incurable, highlighting the need for early detection. Currently, early detection relies on invasive procedures, however recent studies have shown extracellular vesicles (EVs) obtained from liquid biopsies may have clinical utility. EVs transport diverse bioactive cargos throughout the body, play major roles in intercellular communication and, importantly, mirror their cell of origin. In cancer cells, EVs alter the behaviour of the tumour microenvironment (TME), forming a bridge of communication between cancerous and non-cancerous cells to alter all aspects of cancer progression, including the formation of a pre-metastatic niche. Through gene regulatory frameworks, non-coding RNAs (ncRNAs) modulate vital molecular and cellular processes and can act as both tumour suppressors and oncogenic drivers in various cancer types. EVs transport and protect ncRNAs, facilitating their use clinically as liquid biopsies for early BC detection. This review summarises current research surrounding ncRNAs and EVs within BC, focusing on their roles in cancer progression through bi-directional communication with the microenvironment and their diagnostic implications.

10 February 2025 in Trends in Molecular Medicine
Verified
Journal Article
Open access
SRStephen D. Robinson
Stephen D. Robinson
CFChrysa Filippopoulou
Chrysa Filippopoulou
SBSimoni Besta
Simoni Besta
MSMark Samuels
Mark Samuels
ABAndrea Lauer Betrán
Andrea Lauer Betrán
Georgios GiamasGeorgios Giamas
Georgios Giamas
The advent and refinement of state-of-the-art spatial biology technologies have facilitated analysis that combines the advantages of high-throughput single cell analysis with techniques that preserve tissue architecture. This combination of cellular phenotyping with retained spatial context provides a much greater understanding of cellular interactions within the tumour microenvironment (TME). For glioblastoma, with its significant intra-tumoural heterogeneity, cellular plasticity, and complex TME, appreciating and understanding these spatial patterns may prove key to improving patient outcomes. This review examines the advances in spatial biology techniques, discusses how these methodologies are being applied to study glioblastoma, and explores how spatial information improves understanding of the TME. Ultimately, it is this spatial context that will accelerate the identification of more effective treatments for glioblastoma.